Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





GLYCIDOL								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 556-52-5; **Chemical Formula:** C3H6O2
Previously, OSHA had an 8-hour TWA limit of 50 ppm TWA for glycidol. The ACGIH has a limit of 25 ppm TWA for this colorless liquid. The proposed PEL was an 8-hour TWA of 25 ppm. NIOSH (Ex. 8-47) concurred with this limit, and the final rule promulgates this PEL.
Glycidol causes eye, respiratory, and pulmonary irritation. Hine and associates (1956/Ex. 1-331) conducted a study of animal toxicity caused by glycidol exposure and reported that glycidol is irritating to the lungs, with mice and rats exhibiting pneumonitis and emphysema resulting from vapor inhalation. The LC(50) reported for mice is 450 ppm for a four-hour exposure; the 8-hour LC(50) for rats is 580 ppm (Hine, Kodama, Wellington et al. 1956/Ex. 1-331). A single dermal application was only mildly irritating (Draize score 4.5); however, repeated daily skin applications were severely irritating after four days. One drop of pure glycidol in the rabbit eye caused severe but reversible corneal injury (Hine, Kodama, Wellington et al. 1956/Ex. 1-331). In rats, chronic exposures to 400 ppm (seven hours/day for 50 days) did not cause systemic toxicity, but eye irritation and respiratory distress were observed after the first few exposures (Hine, Kodama, Wellington et al. 1956/Ex. 1-331). A study to determine glycidol’s tumorigenic potential on the skin of mice showed negative results (Van Duuren, Langseth, Goldschmidt, and Orris 1967/Ex. 1-1203). OSHA received no comments, other than that of NIOSH (Ex. 8-47), on this substance.
In the final rule, OSHA is establishing an 8-hour TWA limit of 25 ppm TWA for glycidol. The Agency concludes that this limit will protect workers against the significant risk of eye, respiratory, and pulmonary irritation potentially associated with exposures to this substance. The Agency has determined that this limit will substantially reduce these significant risks.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue